Navigation Links
Cellceutix CEO, Leo Ehrlich, Conducts Interview with "Biotech Stock Trader"; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
Date:4/18/2011

r. Ginsburg has authored the patent application for Cellceutix anticancer product Kevetrin™, which has been filed in the United States and other countries and has advised Cellceutix on patent and licensing matters during the past few years.

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism. More information is available on the Cellceutix web site at www.cellceutix.com.

This Press Release contains forward-looking statements that are based on our current expectations, beliefs and assumptions about the industry and markets in which Cellceutix Corporation operates. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause Cellceutix's actual results to be materially different from any future results expressed or implied by these statements. Actual results may differ materially from what is expressed in these statements, and no assurance can be given that Cellceutix can successfully implement its core business strategy and improve future earnings.

The factors that may cause Cellceutix's actual results to differ from its forward-looking statements include: Cellceutix's current critical need for additional cash to sustain existing operations and meet ongoing existing obligations and capital requirements; Cellceutix's ability to implement its new product development and commercialization, enter into clinical trials, expand the intellectual property portfolio, and receive regulatory approvals in a timely and cost-effective manner. All forward-looking statements are also expressly qualified in their entirety by the cautionary statements inclu
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
2. Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun
3. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
4. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
5. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
6. Sonic Innovations Conducts National Training Events for Government Clinicians
7. Impliant Conducts the First Two Implantations of Its New TOPS VersaLink Spinal System
8. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
9. Maine Natural Health Company Conducts Dental Clinical Trial
10. OXIS International Executives Interviewed on StockGoodies.com Radio
11. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 Norgine B.V. today announced ... volume bowel preparation, NER1006, presented at the 79 th ... Gastroenterology (ACG), Philadelphia, PA , has ... and co-primary endpoint of cleansing success. The study demonstrated ... ® in screening colonoscopy patients. [1] ...
(Date:10/19/2014)... 2014 Große Pharmafirmen werden ... Problem dabei ist, dass große Pharmafirmen nicht willens ... teilen. Es war deshalb nicht einfach, ... umso mehr, dass es uns gelungen ist! Wir ... aufzuschreiben - mit einem Vorbehalt - einige haben ...
(Date:10/17/2014)... 2014  Amgen (NASDAQ: AMGN ) today ... M.D., president of Gladstone Institutes and Gladstone,s Robert W. ... "We are pleased to welcome Dr. Sandy Williams ... Bradway , chairman and chief executive officer of Amgen. ... and his direct experience in our industry will both ...
Breaking Medicine Technology:Positive Results from Phase II Data Show NER1006 Achieves High Quality Bowel Cleansing Efficacy 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3
... April 12, 2011 Havel,s market leading EchoStim® ... allows practitioners to perform Peripheral Nerve Blocks (PNBs) ... same time.  The new improved needle has more, ... ultrasound easier, giving even inexperienced practitioners the benefits ...
... April 12, 2011 Perrigo (Nasdaq: PRGO ; ... and Drug Administration (FDA) has concluded its re-inspection of Perrigo,s ... the Company has an acceptable regulatory status, such that any ... once again be eligible for review and approval. ...
Cached Medicine Technology:Perrigo Announces Conclusion of the FDA Re-Inspection 2
(Date:10/20/2014)... JZ Fitness, an independently operated wellness brand ... authorship, international lecturing and community wellness, created by Jenn ... of the JZ Fitness nutrition app, available on iTunes. ... of individuals on nutrition, Jenn Zerling (“JZ”) has developed ... calorie counting or cumbersome food logging. , ...
(Date:10/20/2014)... 20, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Sit and Slim II . ... to purchase or use Sit and Slim II because it ... is promoted as weight loss product on various websites and ... market in 2010 for safety reasons, can significantly increase blood ...
(Date:10/20/2014)... 20, 2014 Succeed is proud to announce ... who participated in the Every Body Walk! campaign ... awareness project that encourages workers to be more active outside ... Program, which concluded at the end of September, was a ... and metro areas. Participating companies gave their staff pedometers ...
(Date:10/20/2014)... California (PRWEB) October 20, 2014 Final Cut ... the release of the Citrus theme for FCPX filmmakers ... would use to describe the Citrus theme” Says Christina Austin, ... easy to look so professional.” , Citrus comes with all ... with the template are: four transitions for added style, a ...
(Date:10/20/2014)... New York, NY (PRWEB) October 20, 2014 ... to be introduced in the U.S., has a lot to ... time when our country recognizes the achievements and contributions of ... marks the anniversary for Punzoné, and today it shares its ... and take a trip to Italy - even if it ...
Breaking Medicine News(10 mins):Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Today Pixel Film Studios Announced the Release of the Citrus theme for Final Cut Pro X 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4
... University of Phoenix has ... Florida Chapter , which will involve fundraising and volunteer ... 25. Additionally, the University is offering four full-tuition scholarships ... or a Master of Science in Nursing, demonstrating its ongoing ...
... RIVER, Mass., April 20 Millstone Medical Outsourcing announced today ... River, MA. Millstone will hold an Open House on ... state and local dignitaries, and friends of the company. ... scheduled to attend. Massachusetts Governor Deval Patrick and Senator ...
... and Israel has identified a genetic variation that influences ... finding is published in the latest edition of the ... Leonard, who heads the Australian Rett Syndrome Study at ... finding was exciting in that it identifies a potential ...
... ability to use objects and tools to perform actions is ... a level that is unique to our species. In a ... Center for Scientific Research (CNRS) and the Paris Descartes University, ... Cortex ( www.elsevier.com/locate/cortex ), researchers have found that brain-lesioned ...
... newly developed technique for the curative treatment of high-grade ... especially to elderly, multimorbid patients for whom the risk ... initial results obtained with this technique at the German ... issue of Deutsches rzteblatt International by Sabine ...
... To Transmit Electronic Claims Through Availity At No ... industry,s premier health information network, today announced it ... claims clearinghouse by Mid Rogue Health Plan, an ... Grants Pass, Oregon. After a successful implementation, Availity ...
Cached Medicine News:Health News:University of Phoenix Announces March of Dimes Partnership in Florida, Offers Four Full-Tuition Nursing Scholarships 2Health News:University of Phoenix Announces March of Dimes Partnership in Florida, Offers Four Full-Tuition Nursing Scholarships 3Health News:Millstone Medical Outsourcing Celebrates New Fall River Facility, Designed to Meet Demand for Advanced Inspection, Clean Room Services 2Health News:New insight into Rett syndrome severity 2Health News:Valve implantation on the beating heart 2Health News:Mid Rogue Health Plan Implements Availity as Its Designated Clearinghouse 2
... Portex® Blue Line ULTRA® Suctionaid® tracheostomy tubes ... removal of secretions from above the tracheostomy ... ULTRA® Suctionaid® tracheostomy tubes provide an additional ... from above the tracheostomy tube cuff helping ...
Manufactured form the same soft siliconized PVC as all Portex® Blue Line® tracheostomy tubes....
... For additional patient safety, ... with an integral 15 mm ... connected to a ventilator, with ... in place , ,Portex® ...
... When the all silicone cuff ... no distinguishable dimension to the ... shaft, yet it can be ... varied airway management needs. TTS™ ...
Medicine Products: